(株)ツムラの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4540/E01018 | TSUMURA & CO. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/04/01 | 日証協 | 424,129株 | +59.21% | 215,538株 | +25.28% | 715,547株 | +2.3% | 204,611株 | +264.6% |
2022/03/25 | 日証協 | 266,393株 | -20.56% | 172,039株 | +233.11% | 699,458株 | -12.48% | 56,119株 | -60.23% |
2022/03/18 | 日証協 | 335,330株 | +113.45% | 51,646株 | -75.52% | 799,185株 | +91.75% | 141,124株 | -67.96% |
2022/03/11 | 日証協 | 157,099株 | -6.2% | 210,988株 | +258.18% | 416,786株 | +12.03% | 440,476株 | +527.02% |
2022/03/04 | 日証協 | 167,484株 | -2.34% | 58,905株 | +51% | 372,023株 | -1.51% | 70,249株 | -63.56% |
2022/02/25 | 日証協 | 171,493株 | +0.78% | 39,009株 | -28.35% | 377,738株 | +3.82% | 192,800株 | +43.77% |
2022/02/18 | 日証協 | 170,162株 | -7.86% | 54,446株 | -27.83% | 363,838株 | +5.38% | 134,107株 | +50.82% |
2022/02/10 | 日証協 | 184,676株 | -5.15% | 75,446株 | +1794.68% | 345,277株 | -2.51% | 88,916株 | +267.74% |
2022/02/04 | 日証協 | 194,698株 | -21.99% | 3,982株 | -77.66% | 354,154株 | -11.94% | 24,179株 | -60.91% |
2022/01/28 | 日証協 | 249,579株 | -18.12% | 17,821株 | -13.41% | 402,156株 | -6.29% | 61,853株 | -6.71% |
2022/01/21 | 日証協 | 304,801株 | -9.3% | 20,581株 | -83.44% | 429,171株 | -2.46% | 66,299株 | -38.54% |
2022/01/14 | 日証協 | 336,050株 | +13.27% | 124,288株 | +59.17% | 439,992株 | +15.19% | 107,879株 | +115.19% |
2022/01/07 | 日証協 | 296,671株 | -9.67% | 78,083株 | +50.36% | 381,977株 | -11.45% | 50,133株 | +3.7% |
2021/12/30 | 日証協 | 328,436株 | 0% | 51,930株 | 0% | 431,362株 | 0% | 48,345株 | 0% |
2021/12/24 | 日証協 | 328,436株 | -8.46% | 51,930株 | -51.4% | 431,362株 | -8% | 48,345株 | -14.12% |
2021/12/17 | 日証協 | 358,780株 | +0.06% | 106,853株 | +39.83% | 468,869株 | -5.93% | 56,293株 | +1.24% |
2021/12/10 | 日証協 | 358,548株 | +11.98% | 76,418株 | +21.42% | 498,428株 | +9.66% | 55,602株 | +32.44% |
2021/12/03 | 日証協 | 320,180株 | +10.7% | 62,937株 | -47.76% | 454,528株 | +5.99% | 41,983株 | +31.51% |
2021/11/26 | 日証協 | 289,244株 | +17.94% | 120,477株 | +10.59% | 428,825株 | +5.48% | 31,925株 | -71.82% |
※株式分割は考慮していませんのでご注意ください。
Page Top